Lexicon Pharmaceuticals, Inc. (LXRX) Insider Ownership

Historic Insider Ownership Trends

Lexicon Pharmaceuticals's three largest insider shareholders as of March 23, 2026 are International S.C.A. Artal (Director, 136.18Mn shares), Us Partners Llc Invus (Director, 5.45Mn shares), Raymond Debbane (Director, 5.30Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
International S.C.A. Artal 0 136,180,481 14 May, 2024
Us Partners Llc Invus 0 5,451,204 09 Aug, 2022
Raymond Debbane 0 5,303,814 01 Aug, 2022
Raymond Debbane 1,906,186 0 27 Feb, 2026
Lonnel Coats Chief Executive Officer 1,098,068 0 29 Feb, 2024
Brian T Crum Svp, General Counsel Secr. 428,802 0 03 Mar, 2026
Participations S.A R.L. Artal 0 408,435 19 Feb, 2026
Global Management, Llc Invus 0 367,145 04 Feb, 2026
Alan J Main Evp, Innov Chem Sciences 339,104 0 03 Mar, 2025
Jeffrey L Wade President And Cfo 324,214 0 29 Feb, 2024
Craig B Granowitz Svp, Chief Medical Officer 323,430 0 03 Mar, 2026
Michael Exton Chief Executive Officer 298,432 0 03 Mar, 2026
Philippe Amouyal 285,174 0 13 May, 2025
Wendy Mcdermott Svp, Human Resources 277,945 0 03 Mar, 2026
Christopher J Sobecki 203,865 0 13 May, 2025
Kenneth B. Kassler-Taub Svp, Regulatory Qa 162,672 0 29 Feb, 2024
Suma Gopinathan Svp, Discovery 150,132 0 03 Mar, 2026
Sam L Barker 124,459 0 13 May, 2025
Scott M Coiante Svp, Chief Financial Officer 105,356 0 03 Mar, 2026
Lisa Defrancesco Svp, Ir And Corp Comm 93,869 0 03 Mar, 2026
Judith L Swain 85,174 0 13 May, 2025
Kristen Alexander Vp, Finance And Accounting 76,368 0 03 Mar, 2025
Kiernan Seth Vp, Chief Commercial Officer 53,136 0 01 Mar, 2023
Robert J Md Lefkowitz 48,364 0 29 Apr, 2024
Alan S Nies 41,046 0 22 May, 2023
Frank Palantoni 40,332 0 22 May, 2023
Diane E. Sullivan 36,810 0 13 May, 2025
Rachel Yap Martens Svp, Partnerships Corp Strat 31,264 0 03 Mar, 2026

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
28 Feb, 2026 Rachel Yap Martens Common Stock A 67,090 - 67,090 D M
28 Feb, 2026 Wendy Mcdermott Common Stock A 27,697 - 149,343 D M
28 Feb, 2026 Suma Gopinathan Common Stock A 14,000 - 88,520 D M
28 Feb, 2026 Brian T Crum Common Stock A 33,457 - 363,658 D M
28 Feb, 2026 Craig B Granowitz Common Stock A 35,790 - 156,042 D M
28 Feb, 2026 Scott M Coiante Common Stock A 160,237 - 160,237 D M
28 Feb, 2026 Lisa Defrancesco Common Stock A 24,674 - 40,251 D M
28 Feb, 2026 Michael Exton Common Stock A 503,263 - 503,263 D M
28 Feb, 2026 Scott M Coiante Common Stock D 54,881 $1.47 105,356 D F
28 Feb, 2026 Lisa Defrancesco Common Stock A 128,190 - 168,441 D M
28 Feb, 2026 Wendy Mcdermott Common Stock A 52,316 - 201,659 D M
28 Feb, 2026 Michael Exton Common Stock D 204,831 $1.47 298,432 D F
28 Feb, 2026 Suma Gopinathan Common Stock A 20,310 - 108,830 D M
28 Feb, 2026 Rachel Yap Martens Common Stock D 35,826 $1.47 31,264 D F
28 Feb, 2026 Brian T Crum Common Stock A 69,386 - 330,201 D M
28 Feb, 2026 Craig B Granowitz Common Stock A 74,226 - 230,268 D M
28 Feb, 2026 Michael Exton Restricted Stock Units D 503,263 - 1,006,527 D M
28 Feb, 2026 Lisa Defrancesco Common Stock D 74,572 $1.47 93,869 D F
28 Feb, 2026 Craig B Granowitz Common Stock A 202,260 - 432,528 D M
28 Feb, 2026 Wendy Mcdermott Common Stock A 144,393 - 346,052 D M